跳至主要内容
临床试验/CTRI/2021/05/033803
CTRI/2021/05/033803招募中不适用

Comparison of chemotherapy combined with percutaneous electroporation and chemotherapy alone in the management of locally advanced carcinoma of the gall bladder

SERB1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2021年1月6日最近更新:

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
30
试验地点
1
主要终点
Survival

研究概览

简要总结

Gall bladder carcinoma (GBC) is the most common malignancyof the biliary tract worldwide. However, most of the patients often presentlate. Therefore, surgical resection may not be possible due to adjacent organinvolvement or local invasion. Chemotherapy is the first line of treatment inunresectable GB masses with dismissal prognosis. In electrochemotherapy (ECT),the short-term electric pulses with high voltage delivered to the tumor, leadsto transient pore formation in the cell membrane which enables the entry ofchemotherapeutic agents into the cells. The hypothesis of this study is thatthe chemotherapy with electroporation may improve the outcome of GBC. This is arandomized control trial of 30 patients with locally advanced GBC who will bedesignated randomly into two equal groups. Group I will receive only chemotherapywhile Group II will receive both chemotherapy and percutaneous electroporation.The primary outcome will be overall survival and the secondary outcome will besafety and quality of life after the procedure.

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
18.00 Year(s) 至 60.00 Year(s)(—)
性别
All

入选标准

  • Patients with unresectable malignant GB masses
  • Life expectancy of at least 3 months.
  • Size of tumor < 6 cm in largest dimension.
  • Total bilirubin level < 2.5 mg/dl.

排除标准

  • Uncorrectable coagulopathy
  • Patients with poor general condition and estimated life expectancy less than 3 months
  • Patients unfit for general anaesthesia
  • Presence of cardiac disease/arrhythmia/heart block
  • Presence of malignant ascites
  • Presence of metastatic disease.

结局指标

主要结局

Survival

时间窗: One year

次要结局

  • Safety of the procedure(Quality of life)

研究者

发起方
SERB
申办方类型
Government funding agency

研究点 (1)

Loading locations...

相似试验